It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...

Doctors in Massachusetts are seeing more children end up in the hospital with flu-related brain complications. It’s not yet clear from national data whether the number of serious flu-related ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...

Beginning in July, the town of Nantucket will expand the COVID surveillance to also include testing for flu and RSV to help predict outbreaks ... drug bust in Lowell’s Belvidere neighborhood ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...

Open Streets Capitol Hill celebrated community engagement, wellness, and economic empowerment, offering a car-free cultural ...

Uy said he wanted to file a bill granting free flu vaccines for senior citizens. “I want all the senior citizens to get their flu vaccines. As it is, the flu vaccines are only given while supply lasts ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Newborns are at risk for serious complications from influenza infections but are not eligible for vaccination until they are ...

Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu ...